Predictors of fat-free mass loss 1 year after laparoscopic sleeve gastrectomy
AbstractPurposeLaparoscopic sleeve gastrectomy (LSG) is one of the most frequently performed bariatric surgery interventions because of its safety and efficacy. Nevertheless, concerns have been raised on its detrimental effect on patient nutritional state that can ultimately lead to the loss of fat-free mass (FFM). There is interest in identifying predictors for the early identification of patients at risk of this highly unwanted adverse because they could benefit of nutritional preventive interventions. Therefore, we investigated whether anthropometric parameters, body composition or resting energy expenditure (REE) measured before surgery could predict FFM loss 1 year after LSG.MethodsStudy design was retrospective observational. We retrieved data on body weight, BMI, body composition and REE before and 1 year after LSG from the medical files of 36 patients operated on by LSG at our institutions. Simple regression, the Oldham’s method and multilevel analysis were used to identify predictors of FFM loss.ResultsAveraged percentage FFM loss 1 year after LSG was 17.0 ± 7.7% with significant differences between sexes (20.8 ± 6.6 in males and 12.2 ± 6.1% in females,p
Authors: Hironaka JY, Kitahama S, Sato H, Inoue M, Takahashi T, Tamori Y Abstract The effects of bariatric/metabolic surgery on glycemic control in obese type 1 diabetic patients are controversial. We herein report a case of a morbidly obese 35-year-old woman who completely recovered from slowly progressive type 1 diabetes (SPIDDM) following laparoscopic sleeve gastrectomy. Preoperatively, her body mass index (BMI) was 49.8 kg/m2 and hemoglobin A1c was 5.7% with intensive insulin therapy. Six months after bariatric/metabolic surgery, her BMI decreased to 33.2 kg/m2 and her glycemic control was normal despite the di...
Authors: Cylke R, Skrzypek P, Ziemiański P, Domienik-Karlowicz J, Kosieradzki M, Lisik W Abstract Laparoscopic sleeve gastrectomy (LSG) is one of the most popular and effective bariatric surgical procedures worldwide. The effect of LSG is mostly dependent on the restrictive mechanism, which makes it more vulnerable to failure. Failing of bariatric procedure is not uncommon and occurs in 6% to 23%. In case of weight loss failure, there are no hard recommendations on the choice of the redo procedure. One of the most novel options, introduced in 2007, relatively simple to perform following LSG is single-anastomosis d...
Publication date: Available online 6 October 2018Source: European Journal of Obstetrics &Gynecology and Reproductive BiologyAuthor(s): Breffini Anglim, Colm J. O’Boyle, Orfhlaith E. O’Sullivan, Barry A. O’ReillyAbstractIntroductionObesity has been shown to negatively impact pelvic floor support and associated urinary incontinence (UI), however little is known regarding the long-term effect of bariatric surgery on urinary incontinence.ObjectiveThe aim of this study is to determine the impact of bariatric surgery on female UI at twelve months post-operatively.Study DesignA prospective cohort study was p...
Over the past 10 years, laparoscopic vertical sleeve gastrectomy (SG) has emerged as the most common bariatric procedure in the world. From a technical perspective, it is a highly reproducible procedure. Despite its relative ease, there is a high degree of variability with regards to the various sub-components or steps involved in its construction. Since its inception, numerous refinements have occurred in the various steps resulting in ongoing improvements with regards to safety, efficacy, and durability.
Conclusionthere are neither certain data which evidence a correlation between obesity and GCT, nor data to support the hypothesis of a higher incidence of GCT after bariatric surgery. Based on our experience in obese patients the finding of GCT in the pre-operatory phase is not an absolute contraindication for bariatric surgery.
ConclusionBariatric surgery in selected cirrhotic patients with portal hypertension is relatively safe and effective.
Conclusion: We detected no significant difference in the duration of operation and intra- or postoperative complication between SMO and MO groups. The possibility of the safety of this procedure in SMO group can be adopted.
Postoperative nausea and vomiting are relevant complications after restrictive bariatric procedures, such as sleeve gastrectomy, mainly secondary to a drastic reduction in the gastric volume. However, other causes can be involved.The aim of this study was to determine the incidence of postoperative nausea and vomiting (PONV) after laparoscopic sleeve gastrectomy (LSG), with staple line reinforcement with oversewing vs buttressing material.
Justification of expansion of BMI criteria for bariatric surgery necessitates an acceptable safety profile to justify the risk-benefit. We aimed to examine 30-day outcomes after laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB), allowing a comparison between the 2 operations and to patients with BMI≥35 k g/m2.
Laparoscopic sleeve gastrectomy (LSG) has become the most prevalent bariatric-metabolic surgical approach in the US with broad benefits from a systemic and metabolic perspective. The aim of this study is to comprehensively describe the short-term multi-organ and metabolic effects of rapid weight loss after LSG.